Sotera Health Company (NASDAQ: SHC) announced a secondary offering of 31,838,253 shares of common stock. The shares are being sold by affiliates of Warburg Pincus LLC and GTCR LLC as selling stockholders.

The company will not offer any shares in the transaction and will not receive proceeds from the sale. Sotera Health will pay the offering expenses under its registration rights agreement obligations.

Goldman Sachs & Co. LLC serves as the underwriter for the offering. The transaction is being conducted through a prospectus, with copies available from Goldman Sachs.

A registration statement for the securities was filed with the Securities and Exchange Commission on February 27, 2024, and became effective automatically.

Sotera Health operates as a provider of sterilization solutions, lab testing and advisory services for the healthcare industry through three business units: Sterigenics, Nordion and Nelson Labs.